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Abstract: 
Purpose 
The purpose of this study was to assess adolescent women's preferences for specific microbicide 
characteristics including pregnancy prevention, timing of application, potential for side effects, 
and whether it targeted human immunodeficiency virus (HIV) or other sexually transmitted 
infections (STI). Potential differences in microbicide preferences by adolescent age group and 
behavioral patterns including engaging in sexual intercourse and use of hormonal contraception 
were examined, as it was hypothesized that as adolescents progress into adulthood and gain 
sexual experience their preferences in microbicide characteristics may shift. 
 
Method 
Adolescent and young women (N = 405, 56.0% African American; 24.0% Euro-American) 
between the ages of 14 and 20 (mean = 17.0, SD = 1.8) were recruited from urban community-
based clinics. Video-Audio Computer-Assisted Self-Interviews were conducted with the young 
women, during which they were asked about their preferences regarding the characteristics of 
hypothetical vaginal microbicides. Conjoint analysis was utilized to determine adolescent 
women's relative preferences for each microbicide characteristic and intent-to-purchase 
microbicides based upon a combination of the selected properties. 
 
Results 
Overall, the results suggest adolescent and young women had an ordered preference for a 
microbicide with (1) no side effects, (2) pregnancy prevention, (3) postcoital application, and (4) 
protection against HIV. Age and behavioral group conjoint analyses resulted in the same pattern 
of preferences as those reported for the entire group. However, women having sex and not using 
hormonal contraception had a stronger preference for postcoital application. 
 
Conclusion 
The findings suggest that young women's ratings of microbicides were sensitive to 
characteristics such as side effects, pregnancy prevention, and timing of application and should 
be considered in microbicide development. The conjoint analysis approach is useful in 
understanding microbicide preferences, and should be utilized with other populations to assess 
preferences for specific microbicide characteristics. 
 microbicides | adolescent women | sexuality | conjoint analysis | adolescent health | Keywords:
sexual health 
Article: 
The search for a woman-initiated prevention method has led to focus on topical microbicides for 
sexually transmitted infection (STI)/ human immunodeficiency virus (HIV) prevention. 
Microbicides are substances that may substantially reduce transmission of STI when applied in 
the vagina or rectum [1]. Some microbicides may also prevent pregnancy, although not all 
microbicides will be contraceptive [2]. Microbicides are not currently commercially available; 
products are in various phases of clinical trials [1]. Most microbicides under development are 
coitus dependent, requiring women to recognize and prepare for sexual situations and be willing 
to use a product that requires some comfort with touching their genitals [3]. The process of 
inserting a microbicide into the vagina may be challenging, as the dialogue around young 
women's sexuality and their bodies is often lacking [4]. Acceptability research, therefore, 
remains crucial to anticipate and prospectively address the kinds of obstacles previously 
associated with other female-initiated products, such as the female condom [5] and [6]. For 
instance, although women enjoyed having more control in using the female condom, they often 
did not like the size and discomfort associated with use or the inability to use it covertly [6]. 
Extant microbicide acceptability research with young women has suggested that contraceptive 
and disease prevention properties, timing of use, and associated side effects are important 
characteristics [7]. The findings suggest that young women generally prefer both pregnancy and 
disease prevention in a single product and insertion with an applicator up to 8 hours in advance 
[8]. In addition, there is a preference for lubricating products [9] and [10] with low amounts of 
messiness [9] and leakage [8]. Previous research also indicated that relevant potential side effects 
may impact microbicide use, including yeast infections, vaginal itching, and allergic reactions 
[7] and [11]. Furthermore, access was an important gauge of acceptability in a group of 
adolescent women. Women indicated that microbicides should be promoted through “adolescent-
specific and girl-specific venues,” including women's magazines [7]. There was also a reported 
desire for microbicides that would be small enough to carry in their pocket, bra, or within cell 
phone or palm pilot cases, and should be distributed through schools and sexuality education 
classes [7]. Most young women preferred over-the-counter availability of microbicides, yet 
stated they would be embarrassed if purchasing the product in the presence of others [7] and [8]. 
 
Thus far, microbicide acceptability research with adolescents has been conducted primarily with 
older adolescents, using individual interview and focus group methodologies [7], [9], [10], [11], 
[12], [13], [14], [15] and [16]. These qualitative methodologies allow for an in-depth assessment 
of individual as well as relational and age-related issues that may influence microbicide use [13] 
and [17]. However, social desirability is often a concern when studying stigmatized or socially 
sensitive issues associated with sexuality [18] and [19]. Past research has shown that using a 
video–audio computer-assisted self-interview (VACASI) format (participants privately 
responding to questions on a computer) for presenting survey questions alleviates the tendency 
for individuals to present themselves positively and answer questions in a socially desirable 
fashion [20]. In addition, women and adolescents report sensitive behaviors more frequently 
when questions are asked using computer interviewing techniques than when participating in a 
face-to-face interview [20], [21] and [22]. Existing microbicide acceptability research with 
adolescents also often lacks detailed attention to the multiple dimensions that must be considered 
simultaneously in a decision to try a product such as a microbicide. The addition of quantitative 
biopsychosocial studies addressing these issues thus complements the existing qualitative 
microbicide acceptability research [8], [23] and [24]. 
 
The purpose of this study was to quantitatively assess, using full-profile ratings based conjoint 
analysis, preferences for specific microbicide characteristics among a young, urban population of 
women. Building on the existing literature we chose to assess young women's preferences for 
pregnancy and STI (including HIV) prevention as well as timing of application and side effect 
potential. It was hypothesized that as women progress through the adolescent years, their relative 
preferences for specific microbicide characteristics may change as a function of their age and 
sexual experience. 
 
Methods 
Study participants 
Participants were 405 adolescent and young women between the ages of 14 and 20 (mean = 17, 
SD = 1.8) recruited from community-based urban health clinics in the Midwestern United States 
in an area with relatively low rates of HIV [25]. See Table 1 for participant demographics. 
Informed consent was obtained from all participants. For women 18 years old and over consent 
was received directly and for those younger than 18 years of age parental permission as well as 
adolescent consent were received. Before obtaining consent, the research assistant explained to 
the young woman (and her parent) the details, procedure, and duration of the study. 
Table 1. 
Participant characteristics 
 Total sample n = 
405 
 
Ages 14–15 n = 
100 
 
Ages 16–17 n = 
124 
 
Ages 18–20 n = 
181 
 
 M SD M SD M SD M SD 
Age 17 1.8 14.6 0.5 16.5 0.5 18.9 0.8 
Grade level completed 10.38 1.66 8.5 0.9 10.2 1.1 11.4 1.2 
 N % N % N % N % 
Race         
 African American 227 56.0 55 55.0 59 55.6 103 56.9 
 Euro-American 97 24.0 19 19.0 37 29.8 41 22.7 
 Other/mixed 49 12.1 17 17.0 12 9.7 20 11.0 
Ethnicity         
 Non-Hispanic 380 93.8 93 93.0 120 96.8 170 93.9 
 Hispanic 22 5.4 7 7.0 4 3.2 11 6.1 
Sexual intercourse         
 Yes 275 69.4 43 43.9 81 65.9 151 86.3 
 No 121 30.6 55 56.1 42 34.1 24 24.0 
Hormonal contraceptive 
use 
        
 Yes 214 55.3 31 34.1 57 47.9 126 71.2 
 Total sample n = 
405 
 
Ages 14–15 n = 
100 
 
Ages 16–17 n = 
124 
 
Ages 18–20 n = 
181 
 
 M SD M SD M SD M SD 
 Condom 32 8.3 4 4.4 14 11.8 14 7.9 
 No 141 36.4 56 61.5 48 40.3 37 20.9 
 
Development of study methodology 
VACASI was used in the study to increase the validity of the information received from the 
adolescent women. The VACASI content for this study was developed from a pilot study 
designed to elicit a range of issues relevant to the examination of adolescents' acceptability of, 
and preference for, microbicides. Focus groups, individual interviews, and dyad interviews were 
conducted, transcribed verbatim, and the results analyzed to determine the characteristics of 
microbicides most often mentioned and about which adolescents expressed the greatest concern. 
Individual interviews and a card sort methodology were used to additionally develop ranked 
preferences for microbicide target (HIV vs. other STI), timing of application (before or after 
sex), contraceptive properties, and types of side effects [26]. Based on these pilot data, a 
VACASI script was developed, further pilot tested, and finalized for use in the current study. 
 
Study procedure 
After informed consent was received, the young women were given a computer and headphones 
in a private exam room to begin the questionnaire. The VACASI began with participants being 
asked to choose one of four possible “guides” whose face and voice were used throughout the 
VACASI. Guides were young women (approximately 18–20 years old) who were professional 
actors of varied ethnic appearance and voice. The guides were used to increase young women's 
level of comfort with the interview [27]. Following the choice of a guide, more information was 
given about the microbicide and a product sample was shown. The participant was then asked 
multiple demographic and sexual behaviors questions and presented with microbicide vignettes 
that asked her to rate the likelihood of buying each microbicide. The self-interviews were 
completed in English and lasted 25–45 minutes. Participants received $20 compensation for the 
time and effort involved in completing the questionnaire. The protocols for the entire project 
were approved by the University's institutional review board. 
 
Study Measures 
Background 
Demographic information was collected from each participant including age, race, ethnicity, and 
education. Participants answered questions regarding their sexual behaviors (e.g., Has a partner 
ever put his penis in your vagina?) and contraceptive use (e.g., What kinds of birth control have 
you used in the past month?). 
 
Microbicide preferences 
Eight microbicide formulas were uniquely described along four specific dimensions (with 
multiple attributes within each dimension) to assess participants' relative preference for each 
individual property. Table 2 summarizes the microbicide formulas. The first dimension, 
contraception, contained two attributes—whether the microbicide would prevent pregnancy or 
not. The second dimension, timing, was related to the timing of microbicide application in 
relation to coitus (attributes—1 hour precoital, 15 minutes precoital, or 10 minutes postcoital 
application). The third dimension, target, was defined in terms of what infections were prevented 
by the microbicide (attributes—HIV only or other STI but not HIV). The final dimension, side 
effects, varied with respect to side effects (attributes—burning and itching in 10% of women or 
no side effects at all). The product profiles were presented in random sequence across 
participants and women were asked to rate their intent to purchase each microbicide formula. 
Table 2. 
Characteristics of hypothetical microbicides 
Formula Contraception Side effects Timing Target 
1 yes yes 15 min before STI 
2 yes no 10 min after HIV 
3 yes yes 1 hour before HIV 
4 no no 15 min before HIV 
5 no no 1 hour before STI 
6 no yes 10 min after STI 
7 no yes 1 hour before HIV 
8 yes no 1 hour before STI 
 
Intent to purchase microbicides 
Intent to purchase microbicides was measured by asking participants to rate each of eight 
microbicides using a 7-point likelihood scale, ranging from “extremely unlikely to buy” to 
“extremely likely to buy.” As we were uncertain what the cost of microbicides would be, we 
asked respondents to assume that the cost of microbicides would be approximately the same as 
condoms. Recent estimates suggest that microbicides will cost approximately $1 per application 
[28]. 
 
Data analysis 
Data management and analysis were performed using SPSS 15.0 [29]. Descriptive statistics were 
conducted to assess the demographic variables. The quantitative marketing research technique, 
conjoint analysis, was employed to assess preference for specific microbicide characteristics and 
formulas among young women. Conjoint analytic techniques are commonly used to evaluate 
how product characteristics influence the product acceptability, often while the product is still in 
development [30]. Conjoint analysis allows for the assessment of the relative preference women 
have for microbicide characteristics (e.g., contraceptive properties, timing of application). 
 
The full-profile ratings-based conjoint analysis technique used in this study incorporates a 
fractional factorial design and is a regression-based analytic approach to examine how different 
product dimensions influence intent to purchase [31]. Conjoint analysis allows for multiple 
product characteristics to be simultaneously assessed with a relatively small number of items that 
minimizes the burden to the respondent (i.e., a fractional factorial design) [8] and [32]. The 
conjoint analysis technique has been applied in several health care preference studies [33], [34], 
[35], [36] and [37] and one other microbicide acceptability study, with considerable differences 
in terms of sample demographics and product characteristics [8]. 
 
Using the aforementioned dimensions (contraception, timing, target, and side effects), 24 
microbicide formulas would have to be rated to assess every combination of attributes. However, 
a fractional factorial design allows for the examination of a representative subsample of eight 
microbicide formulas, thus reducing respondent burden (see Table 2 for microbicide 
formulations). By having the respondents evaluate each of the eight product constructions, we 
were able to estimate the effect of each product characteristic on purchase intentions. A 
limitation of the fractional factorial design is that only the main effects of each dimension can be 
assessed, as only a relatively small subset of all possible combinations are presented. 
 
Full-profile rating-based conjoint analysis results in part-worth utilities (PWU) and importance 
scores [8] and [32]. PWU reflect the relative value placed on the specific attributes within each 
dimension, for example, contraceptive compared to noncontraceptive. A negatively rated part-
worth utility indicates a relative antipathy for a particular attribute, whereas a positively rated 
part-worth utility indicates a relative preference for an attribute. This approach to conjoint 
analysis also provides importance scores, which, summed across all dimensions equal 100. The 
higher the importance score for a given dimension, the greater the influence on microbicide 
ratings. PWU summed within a given dimension equal zero with a greater range in utilities 
translating into a higher importance score for a given dimension. 
 
Results 
Descriptive statistics: overall sample 
The women (N = 405) were between the ages of 14 and 20 years, with a mean age of 17 (SD = 
1.8). Of these women, 56.0% (n = 227) were African American, 24.0% (n = 97) were Euro-
American, 5.4% (n = 22) were Latina, and the remainder identified as other or mixed ethnic and 
racial backgrounds. On average, women had completed 10.3 years of education (SD = 1.6), with 
23.5% (n = 94) having completed high school and 6.8% (n = 27) having completed some college. 
Of the women, 67.7% (n = 275) had engaged in sexual intercourse, and 52.8% (n = 214) were 
currently using a hormonal contraceptive. Participant characteristics for the entire sample and the 
groups divided by age category are summarized in Table 1. 
 
Descriptive statistics: age and behavioral group 
As we were interested in developmental changes, women were divided by age and sexual and 
contraceptive experiences into groups. This allowed between group comparisons with respect to 
the microbicide preference profiles provided by the conjoint analyses. The three age categories 
were defined as: 14- and 15-year-olds (n = 100, 24.9%), 16- and 17-year-olds (n = 124, 30.6%), 
and women age 18 to 20 (n = 181, 44.7%). Conceptually, these age groups (i.e., 14- and 15-year-
olds; 16- and 17-year-olds; and those 18 and older) represent middle adolescence, late 
adolescence, and emerging adulthood. In addition, the women 18 years of age and older, as legal 
adults, differ in sexual rights from the rest of the sample. Differences existed among age groups 
in terms of sexual behaviors and contraceptive experience. Among 14- to 15-year-olds, less than 
half had engaged in sexual intercourse (43.9%, n = 43) or were using hormonal contraception 
(34.1%, n = 31). The majority of the age 18 and older women had engaged in sexual intercourse 
(86.3%, n = 151) and were using hormonal contraception (71.2%, n = 126). In contrast, less than 
half of 16- to 17-year-olds were using hormonal contraception (47.9%, n = 57), although most 
reported ever having sexual intercourse (65.9%, n = 81). Therefore, the behavioral groups 
consisted of women who had never had intercourse (n = 121, 29.9%), were engaging in 
intercourse and not using hormonal contraception (n = 89, 22.0%), and were engaging in 
intercourse and using hormonal contraception (n = 181, 44.7%). Group characteristics are 
summarized in Table 1. 
 
Microbicide intent to purchase 
On the 7-point response scale (ranging from 1 = extremely unlikely to buy to 7 = extremely 
likely to buy), the mean intent-to-purchase ratings ranged from 3.38 (SD = 2.04) to 5.35 (SD = 
1.76) across the eight different microbicide formulas. The microbicide with the highest intention 
rating had these properties: contraceptive, application 10 minutes postcoitus, protecting against 
HIV only, and not having side effects. The microbicide with the lowest intention to purchase had 
the following characteristics: noncontraceptive, application 1-hour precoitus, protecting against 
HIV only, and having side effects. 
 
Microbicide preference: entire sample 
Relative attribute preferences, as determined by conjoint analysis, could only be calculated from 
subject data in which there was variability across the eight microbicides. Twenty-two women 
(5.4% of the total sample) rated all microbicides at the same level and were therefore not 
included in the conjoint analysis results. The PWU results (Figure 1) for the remaining 94.6% of 
the sample indicated strong relative preferences for contraceptive properties (PWU, 0.37) and for 
no side effects (PWU, 0.55). In addition, there was a moderate preference for 10-minute 
postcoital application (PWU, 0.14), and a slight preference for a microbicide that targets other 
STI, but not HIV (PWU, 0.04). In contrast, the following microbicide attributes were viewed as 
relatively less preferable: no contraceptive action (PWU, −0.37), side effects (PWU, −0.55), 
applied 1 hour before coitus (PWU, −0.14), and targeted HIV only (PWU, −0.04). 
 
Figure 1.  
PWU for the preference for each characteristic among the entire sample of adolescents. 
Reflecting the PWU results, the majority of women indicated a relative preference for 
contraception (n = 249; PWU = 0.13 to 2.38). However, a reasonably large minority of 
respondents expressed a relative preference for noncontraception (n = 74; PWU = 0.13 to 2.25), 
with the remaining women not distinguishing between contraception and noncontraception. Also, 
although most women expressed a relatively negative response to side effects (n = 292; PWU = 
−0.13 to −2.50), for 43 women, side effects were viewed as relatively unimportant as reflected in 
low, positive PWU (ranging from 0.13 to 0.88). With respect to timing, 161 indicated a 
preference for postcoital application (PWU = 0.08 to 3.50), 92 preferred 15 minutes precoitus 
(PWU = 0.25–2.83), and 89 expressed a preference for 1-hour precoitus (PWU = 0.17–2.67). 
Respondents were relatively equally divided in preference for either HIV prevention (n = 152; 
PWU = 0.13 to 2.50) or prevention of other STDs (n = 168; PWU = 0.13–2.25). 
 
Side effects most strongly influenced ratings with an importance score of 50.1 followed by 
contraceptive properties with an importance score of 33.6 and timing with an importance score 
of 13.0. The microbicide target did not substantially influence ratings (importance score, 3.4). 
Importance scores, in total, add up to 100; therefore, side effects and contraceptive effect were 
the strongest influences on young women's microbicide preferences. 
 
Microbicide preference: age and behavioral groups 
We calculated conjoint analysis results separately on the basis of both age group and sexual and 
contraceptive behavior experiences. Results indicated that all of the age and behavioral groups 
had the same pattern of preferences for the combination of microbicide characteristics as the 
overall group (i.e., not having side effects followed by having contraceptive properties). To 
evaluate differences that may exist within the behavioral groups we conducted a series of 
analysis of variance (ANOVA) tests with sexual and contraceptive behavior group as the 
independent variable and the PWU associated with different microbicide attributes (i.e., no side 
effects) as the dependent variables. After the application of the Dunnet's post hoc test, the results 
indicated one significant ANOVA [F (2, 342) = 3.6, p < .05], suggesting that women having sex 
and using condoms had a stronger preference for postcoital application compared to those 
women currently having sex and using hormonal contraception. 
 
Discussion 
This study examined adolescent and young women's preference for specific microbicide 
characteristics utilizing full-profile ratings-based conjoint analysis. Similar to existing research 
[7] and [11], young women's preferences were sensitive to side effects, contraceptive properties, 
and timing of application. Specifically, adolescent women reported an ordered preference for a 
microbicide with no side effects, having contraceptive properties, applied 10 minutes 
postcoitally, and protecting against STI rather than HIV. 
 
Young women's preferences were most influenced by side effects and contraceptive properties. 
Lack of side effects was the most preferential microbicide characteristic for the overall sample. It 
is notable that young women would be primarily concerned with side effects given that the 
option was that there would either be no side effects or side effects in 10% of women. This may 
reflect young women's experiences with negative side effects of existing hormonal contraceptive 
methods [10] or be a result of young women's assumption that they would be the ones to have 
side effects. The concern related to side effects for these women suggests it will be essential for 
healthcare providers to discuss the likelihood of side effects with young women so they are not 
surprised and will continue to use microbicides for protection. Contraceptive properties were the 
second most favored characteristic for the young women, including for women who were 
currently using hormonal contraception. These results may reflect the saliency of pregnancy in 
this population of young women, and will be an important characteristic to discuss with women 
as early generation microbicides may not be contraceptive [2]. 
 
In contrast to other research that suggests adolescent women have a preference for microbicide 
application up to 8 hours in advance [8], young women in the current study preferred a 
microbicide that was applied 10 minutes postcoitus, or 15 minutes precoitus, compared to one 
applied 1 hour before intercourse. Women's relative preference for the 10 minutes postcoital 
application could be explained by their desire to separate microbicide use from intercourse. This 
result may also be reflective of the appeal of the possibility of using microbicides surreptitiously 
due to the difficulties often associated with sexual communication and the ability to avoid direct 
discussions related to microbicide application that is after coitus [9] and [15]. Similarly, the 
antipathy toward the 1-hour precoital application is likely explained by the often unplanned 
nature of sexual interactions among adolescents [10]. In addition, although the lubricating effects 
of a precoital microbicide may be attractive to some young women, postcoital application was 
viewed in a more positive light; this result may be due to lack of knowledge related to the 
potential of lubrication to enhance sexual comfort. The lubricating potential of microbicides may 
be an attractive characteristic, especially when used in conjunction with condoms to increase 
comfort for individuals who choose to use condoms. 
 
As a group, adolescent and young women were slightly more accepting of a vaginal microbicide 
that prevented STI other than HIV compared to a vaginal microbicide that protected against HIV 
only. This preference is interesting, as HIV has far fewer treatments than those available to treat 
and cure other STI [38]. However, the relative disinterest in HIV prevention may reflect the very 
low prevalence of HIV and the saliency of other STI for the study population [35] and [39]. HIV 
prevalence will likely have implications for microbicide marketing based on geography, where 
highlighting potential for HIV protection may be more useful in higher prevalence areas, 
whereas highlighting other characteristics may be more beneficial in other areas. 
 
Our findings suggest that young women's ratings of microbicides were responsive to a variety of 
characteristics including side effects, pregnancy prevention, and timing of application. They 
were most likely to indicate an intent to purchase a microbicide that was contraceptive, applied 
10 minutes postcoitally, protected against STI, and did not have side effects. However, it is 
important to note that a substantial number of the women preferred characteristics other than 
those identified as preferred by the group as a whole. These findings suggest that in the future a 
variety of microbicide formulations will be useful as not all women (and their partners) will have 
preferences for the same characteristics. In addition, although we did not find a significant 
difference in preferences by age group or behavioral factors, age, sexual experiences, and use of 
hormonal contraceptives may play an important and complex role in microbicide preferences and 
utilization based on specific microbicide characteristics. Thus, more mixed methodological work 
will be helpful in examining the individual variation in sexual and contraceptive experience. 
Shifts in attitudes across varying levels of sexual experiences may reflect developmental changes 
in reproductive health behaviors and priorities, and may be important considerations for the 
promotion and social marketing of microbicides. The availability of microbicides with differing 
characteristics will allow microbicide formulas to be targeted to the specific needs of women and 
may increase the likelihood of use. That said, we recognize the ongoing difficulties associated 
with creating one effective microbicide and realize that this variety will not be available for some 
time. 
 
Full-profile ratings-based conjoint analysis, a marketing research tool, was used in the study to 
examine adolescent women's relative preference for microbicide characteristics. This approach to 
data analysis is a unique way of examining the complicated microbicide preferences of 
adolescent women and how these preferences might differ based upon individual factors. 
Although conjoint analysis has been used effectively in marketing research and suggests a level 
of interest, it does not indicate the likelihood of continued use [8], [32], [36] and [37]. However, 
intention has been shown to be predictive of actual behavior [40] and without an actual product 
available the starting point needs to be intent as intent is a key antecedent to behavior. In 
addition, the dimensions chosen for the study may not be reflective of an actual product, as we 
have limited knowledge regarding the characteristics of early generation microbicides [1] and 
[28]. Using the VACASI technique to collect data in the present study allowed for more privacy 
in data collection, helping prevent much of the response bias and socially desirable answering 
often associated with collecting sexuality related data. Therefore, it is probable that the intent-to-
purchase results reported here are more valid than results collected during a face-to-face 
interview. 
 
Because of the nature of the clinics in which these women were recruited, incidence of sexual 
intercourse as well as experiences with STI might be greater than in the general population, and 
their preferences may not be reflective of the larger population. In addition, as women were 
asked about hypothetical microbicide products, we were not able to evaluate what their 
experience would be with actual microbicide use. The inability to assess young women's use of a 
product disregards their bodily experience (either positive or negative) or how a microbicide 
would be introduced into and negotiated within a sexual relationship which should be examined 
in future research. In addition, we were not able to capture the relationship specific information 
(e.g., quality, length) that may impact women's desire and ability to use a future microbicide 
[10]. 
 
This study expands on existing adolescent microbicide acceptability research with future 
research in this area potentially benefitting from utilizing conjoint analysis. Additionally, the 
combination of conjoint analysis techniques with qualitative methodologies could be useful in 
assessing microbicide preferences and reasoning at an individual level. This combined approach 
would allow for a more in-depth examination of some of the issues related to young women's 
sexual experiences, the relationship with their bodies, and their sexual interest and pleasure. For 
instance, recent work has suggested that the lubricating properties of microbicides may be a 
highlight of use and may be of higher value to some women compared to others [9] and [10]. 
The implications of introducing a product with lubricating qualities into a sexual interaction and 
the potential impact on relationship and sexual satisfaction should be assessed as they may be 
important determinants of continued use. In addition, relationship and communication quality 
and the effects these factors have on overall microbicide acceptability and use as well as the 
possibility of surreptitious use should be examined. Specifically, these factors should be 
examined to determine acceptance of covert microbicide use as well as what the potential 
consequences of not telling the partner may be for young women. Vaginal microbicides are a 
promising prevention strategy and promotion strategies should address the variable microbicide 
preferences specific to the target population. 
 
In conclusion, as microbicide development continues, attention will need to focus on the impact 
of preferred characteristics for adolescent women and how preferences may change as a function 
of developmental stage and sexual and contraceptive experience. Young women are clearly an 
important target for microbicide promotion, and the results of this study suggest that they have 
interest in microbicide use. Their preferences will likely influence the focus of targeted social 
marketing and education programs for microbicide use. Focusing on young women will be 
essential to encourage utilization in this population, which remains at higher risk for the potential 
negative effects of sexual initiation and to promote overall healthy sexual development. 
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